Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 69

Results For "cancer"

1027 News Found

Celanese support the sustained-release drug delivery market
News | October 13, 2022

Celanese support the sustained-release drug delivery market

Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions


PM Modi dedicates to the nation various healthcare facilities in Civil Hospital Asarwa, Ahmedabad
News | October 12, 2022

PM Modi dedicates to the nation various healthcare facilities in Civil Hospital Asarwa, Ahmedabad

Prime Minister said that it is a huge day for health in Gujarat and congratulated everyone associated with these projects for completing them on time.


Sitaram Jaipuria Foundation felicitates doctors at the Medical & Healthcare Excellence Awards 2022
News | October 11, 2022

Sitaram Jaipuria Foundation felicitates doctors at the Medical & Healthcare Excellence Awards 2022

Monetary awards worth Rs 1.20 crore were presented amongst the winners for their remarkable contributions


Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial
Diagnostic Center | October 09, 2022

Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial

Study achieves primary endpoint of radiographic progression-free survival


Matt Sause elevated as new CEO of Roche Diagnostics
People | October 04, 2022

Matt Sause elevated as new CEO of Roche Diagnostics

Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.


Moderna creates new executive committee role for product launches
News | October 04, 2022

Moderna creates new executive committee role for product launches

Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion


Sumitovant Biopharma and Sumitomo Pharma to acquire outstanding shares of Myovant Sciences
News | October 03, 2022

Sumitovant Biopharma and Sumitomo Pharma to acquire outstanding shares of Myovant Sciences

The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.


South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData
Diagnostic Center | September 28, 2022

South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData

There is also a growing interest in whole generation sequencing (WGS)


Zentalis promotes Kevin Bunker to Chief Scientific Officer
People | September 28, 2022

Zentalis promotes Kevin Bunker to Chief Scientific Officer

Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.


Novartis unveils new focused strategy
News | September 27, 2022

Novartis unveils new focused strategy

Transformation to pure-play Innovative Medicines company nears completion